FDA Officially Ranks Condoms for Anal and Vaginal Use as 'Class II' Gadgets
Published Date: 5/8/2026
Rule
Summary
The FDA is officially classifying external condoms for anal or vaginal sex as Class II devices, meaning they have special safety rules but aren’t super strict. This change helps make sure condoms are safe and effective while making it easier for new, innovative products to reach you. The new rules took effect on May 8, 2026, and could speed up how quickly better condoms hit the market without extra costs.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Condoms Reclassified to Class II
The FDA has officially classified external condoms for anal or vaginal intercourse as Class II (special controls). FDA says this classification provides a reasonable assurance of safety and effectiveness and will enhance patient access to innovative condom products by reducing regulatory burdens; the order is effective May 8, 2026 (classification applicable February 23, 2022).
New Testing and Labeling Rules for Makers
Manufacturers must meet new special controls: clinical acute failure modes studies for total and individual failure rates; non‑clinical performance testing including mechanical/material integrity and (for non‑latex materials) viral penetration testing; biocompatibility evaluation; shelf‑life performance and package integrity data; and specific labeling elements. These controls are codified at 21 CFR 884.5305 and apply to devices classified as external condoms for anal or vaginal intercourse.
Premarket 510(k) Notification Required
FDA states that external condoms for anal or vaginal intercourse are subject to premarket notification under section 510(k) of the FD&C Act and that it has not determined these devices should be exempt under section 510(m). Sponsors must therefore submit a 510(k) to market these devices unless FDA later exempts them.
Labels Must Give Clear Safety & Effectiveness Info
Required labeling must include (if indicated for vaginal intercourse) a contraceptive effectiveness table comparing typical and perfect use pregnancy rates; statements on lubricant compatibility; statements of adverse events (including infection, pregnancy, tissue reaction, mechanical injury, improper use); an expiration date; STI protection specifics; a statement that risks are not eliminated; a warning about failure during anal intercourse if adequate lubricant is not used; a warning that the device is single‑use; and a precaution about allergy risk.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13778 — Medical Device User Fee Amendments; Public Meeting; Request for Comments
The FDA is planning a public meeting on August 5, 2026, to talk about renewing fees that medical device makers pay to help speed up device reviews from 2028 to 2032. This affects companies making medical devices and could impact how much they pay and how fast their products get approved. The current fee program ends in September 2027, so the FDA wants your thoughts before finalizing new rules and fees.
2026-13716 — New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
The FDA just updated the rules for new animal drugs, approving several new and generic medicines for pets and farm animals from early 2026. These changes help keep animal treatments safe and effective, and the updates take effect right away on July 7, 2026. If you’re a drug maker or animal caretaker, these approvals and sponsor changes could impact what medicines are available and when.
2026-13616 — Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The FDA is officially pulling the plug on 34 drug approvals because the companies stopped selling these medicines. This change kicks in on August 5, 2026, and it mainly affects drug makers like Endo Operations and Pfizer. No money penalties here—just a clean break, but companies can ask to reapply if they want to bring the drugs back.
2026-13534 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
The FDA is asking for public feedback on how it collects information for formal hearings and administrative rules. This affects businesses and people who interact with the FDA, with no new costs but a chance to improve paperwork processes. Comments are due by August 5, 2026, so don’t miss your chance to weigh in!
2026-13519 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
The FDA is asking for public feedback on their paperwork rules for approving the most important and risky medical devices, like life-support machines. This review helps keep devices safe and effective before they hit the market. If you have thoughts, you’ve got until August 5, 2026, to share them—no cost changes, just a check-in on the info they collect.
Previous / Next Documents
Previous: 2026-09148 — Implementation of the Administrative False Claims Act; Correction
The Federal Labor Relations Authority fixed a few wording mistakes in its new rules for the Administrative False Claims Act, which helps catch and stop false claims against the government. These corrections make the rules clearer and officially take effect on May 26, 2026. If you work with government claims or legal procedures, these updates keep things running smoothly without changing any costs or deadlines.
Next: 2026-09155 — Changes to National Firearms Act Tax Remittance Provisions
Starting June 10, 2026, the ATF is updating its rules to match new laws that lower the tax rates on certain National Firearms Act (NFA) guns. This means folks who deal with these firearms will pay less tax when registering or transferring them. The changes keep the rules clear, fair, and up-to-date with the latest law.